基本信息
浏览量:334
职业迁徙
个人简介
My interests at UCI will be to incorporate novel and targeted therapies in the treatment of upper aero-digestive tract malignancies. I am especially interested in Lung cancer in never-smokers who harbor specific genetic alterations: activating mutations in the epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) translocation-fusion. I currently am the Principal Investigator in clinical trials that investigate second generation EGFR tyrosine kinase inhibitors (TKIs), acquired resistance to first generation EGFR TKIs, and inhibitor to the ALK (Crizotinib). Additionally, I have international collaboration with investigators in Asia to investigate the difference in lung cancer according to ethnicity, and the role of environmental tobacco smoke (ETS) and the occurrence in the genetic alterations in lung cancer patients who are never-smokers.
研究兴趣
论文共 453 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Lung cancer (2024): 75-80
AME Clinical Trials Review (2024): 39-39
Faustine X Luo,Sai-Hong Ignatius Ou
Lung cancer (2024): 69-73
Brian Warnecke, Angelo Cabal, Zhaohui Arter, Hari B. Keshava,Jeremy P. Harris,Sai‐Hong Ignatius Ou,Misako Nagasaka
Journal of clinical oncologyno. 16_suppl (2024): 3071-3071
Lung Cancer (Auckland, N.Z.) (2024): 81-85
The Lancet Respiratory medicineno. 9 (2024): 656-657
Sai-Hong Ignatius Ou,Xiuning Le,Misako Nagasaka,Thanyanan Reungwetwattana, Myung-Ju Ahn,Darren W. T. Lim,Edgardo S. Santos,Elaine Shum,Sally C. M. Lau,Jii Bum Lee, Antonio Calles, Fengying Wu,Gilberto Lopes, Virote Sriuranpong, Junko Tanioki, Hidehito Horinouchi,Marina C. Garassino,Sanjay Popat,Benjamin Besse,Rafael Rosell,Ross A. Soo
Lung cancer (2024): 87-114
Molly Siu-Ching Li,Sai-Hong Ignatius Ou
Journal of Thoracic Oncologyno. 6 (2024): 855-857
Medno. 2 (2024): 115-117
加载更多
作者统计
#Papers: 455
#Citation: 22803
H-Index: 73
G-Index: 143
Sociability: 8
Diversity: 3
Activity: 258
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn